Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Proceedings of the National Academy of Sciences of the United States of America|December 10, 2003
Molecular basis of calcium regulation in connexin-32 hemichannelsJuan M Gómez-Hernández, Marta de Miguel, Belen Larrosa, et al.Annals of Neurology|April 27, 2005
Severe neuropathy with leaky connexin32 hemichannelsGrace S Lin Liang, Marta de Miguel, Juan M Gómez-Hernández, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 26, 2021
Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohortSonsoles Salto-Alejandre, Zaira R Palacios-Baena, José Ramón Arribas, et al.Hepatology (Baltimore, Md.)|March 7, 2024
Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosisJuan Berenguer, Teresa Aldámiz-Echevarría, Víctor Hontañón, et al.Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 12, 2024
Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815)M Eulalia Valencia, Tatiana Pirogova, Delia Romera, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2026
Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results from the VOLVER Clinical TrialMaría De Lagarde, Rosa De Miguel, Mayra A Sigcha, et al.AIDS and Behavior|June 15, 2025
Preparing for the Next Physician's Visit: Usability and Validity of a Mobile Health App for People Living with HIVJoanna Cano-Smith, Ana Delgado-Hierro, Luis Ramos-Ruperto, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 25, 2021
HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018Leire Pérez-Latorre, Juan Berenguer, Rafael Micán, et al.Open Forum Infectious Diseases|November 28, 2025
Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022-2024)Pablo Ryan, Juan Berenguer, Luis Ramos-Ruperto, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2025
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study)Sergio Serrano-Villar, Laura Martín-Pedraza, Juan Tiraboschi, et al.Pageof 2